About

Platform

Applications

Media

Contact

Careers

Press Releases

Profluent Successfully Edits Human Genome with OpenCRISPR-1, the World’s First AI-Created and Open-Source Gene Editor

Profluent

2024

Profluent Successfully Edits Human Genome with OpenCRISPR-1, the World’s First AI-Created and Open-Source Gene Editor

Profluent

2024

Profluent Successfully Edits Human Genome with OpenCRISPR-1, the World’s First AI-Created and Open-Source Gene Editor

Profluent

2024

Profluent Secures $35M in Additional Funding

Profluent

2024

Profluent Secures $35M in Additional Funding

Profluent

2024

Profluent Secures $35M in Additional Funding

Profluent

2024

Profluent Announces $9M Seed Round

Profluent

2023

Profluent Announces $9M Seed Round

Profluent

2023

Profluent Announces $9M Seed Round

Profluent

2023

Blog

Generating Proteins with Atomic-level Control

Blog Post

2024

Generating Proteins with Atomic-level Control

Blog Post

2024

Generating Proteins with Atomic-level Control

Blog Post

2024

Editing the Human Genome with AI

Blog Post

2024

Editing the Human Genome with AI

Blog Post

2024

Editing the Human Genome with AI

Blog Post

2024

Media Features

For more on our scientific publications, view our platform.

Take Me There

About

Platform

Applications

Media

Contact

Careers

About

Platform

Applications

Media

Contact

Careers

About

Platform

Media

Applications

Careers

Contact

About

Platform

Media

Applications

Careers

Contact

About

Platform

Media

Applications

Careers

Contact

Press Releases

Press Releases

Press Releases

Profluent Successfully Edits Human Genome with OpenCRISPR-1, the World’s First AI-Created and Open-Source Gene Editor

Profluent Successfully Edits Human Genome with OpenCRISPR-1, the World’s First AI-Created and Open-Source Gene Editor

Profluent Successfully Edits Human Genome with OpenCRISPR-1, the World’s First AI-Created and Open-Source Gene Editor

Profluent Secures $35M in Additional Funding

Profluent Secures $35M in Additional Funding

Profluent Secures $35M in Additional Funding

Profluent Announces $9M Seed Round

Profluent Announces $9M Seed Round

Profluent Announces $9M Seed Round

Blog

Blog

Blog

Generating Proteins with Atomic-level Control

Generating Proteins with Atomic-level Control

Generating Proteins with Atomic-level Control

Editing the Human Genome with AI

Editing the Human Genome with AI

Editing the Human Genome with AI

Media Features

Media Features

Media Features

Generative A.I. Arrives in the Gene Editing World of CRISPR

Giving Structure to Language: Profluent’s AI Models Move toward Precise and Steerable Protein Design

Profluent on A.I. Decoded

The AI effect: How a hot computing tool is tying ‘bio’ and ‘tech’ closer than ever

‘If you could hallucinate a protein’: Profluent snags $35M for generative AI models

Profluent, spurred by Salesforce research and backed by Jeff Dean, uses AI to discover medicines

Fortune 50 AI Innovators

Large language models learn to speak biology

Now AI Can Be Used to Design New Proteins

Facebook, TikTok, and proteins: Why big tech companies are betting on AI protein design

ChatGPT-like AI creates new bacteria-killing proteins

AI has designed bacteria-killing proteins from scratch – and they work

Profluent debuts to design proteins with machine learning in bid to move past 'AI sprinkled on top'

Meet 7 startups and labs that are capitalizing on the kind of ‘generative’ A.I. that powers ChatGPT

How AI That Powers Chatbots And Search Queries Could Discover New Drugs